PlainRecalls
FDA Drug Low Class III Terminated

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

Reported: September 22, 2021 Initiated: September 3, 2021 #D-0801-2021

Product Description

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Units Affected
1,160 ten-pack cartons
Distribution
Nationwide within the USA and India
Location
Chicago, IL

Frequently Asked Questions

What product was recalled?
Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21. Recalled by Meitheal Pharmaceuticals Inc. Units affected: 1,160 ten-pack cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on September 22, 2021. Severity: Low. Recall number: D-0801-2021.